Industry Snapshot: North American Pharmaceutical-Biotech Capital Investment Jumps to $14.7 billion for 2006
Industry Snapshot: North American Pharmaceutical-Biotech Capital Investment Jumps to $14.7 billion for 2006
Attachment: 2006 Pharma-Biotech Industry Planned Project Spending Chart, Pharma-Biotech Industry Project Spending Analysis
Spending in 2005 was spread throughout all of the North American regions, with the Great Lakes emerging as the somewhat surprising leader, with 54 projects valued at $2.8 billion scheduled to begin construction. - Includes 2006 Pharma-Biotech Industry Planned Project Spending Chart and Pharma-Biotech Industry Project Spending Analysis
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- U.S. Home to Billions' Worth of 2Q ESG Project Kickoffs
- Japan Hosts $832 Million in CDMO/CMO-Related Pharma Projects
- Turner Construction Involved in More than $24 Billion Worth of U.S. Project...
- Medical Devices & Equipment Sector Brings Billions in Spending to the U.S.
- South Korea's PharmaResearch BIO Readies to Boost Exports
Quick Links
- Home
- About Us
- Contact Us
- For Traders
Global Market Intelligence
- GMI Database Platform
- GMI Platform Tools
- Industry Coverage
- Analytics & Insights
- Advertising
